Summit Pharmaceuticals International, RIKEN to Forge Alliance

Sumitomo announced March 8 that its biotech subsidiary Summit Pharmaceuticals International (SPI) and RIKEN signed a business partnership agreement on January 27. Under this agreement, the two parties will collaborate in the fields of pharmaceutical and medical instruments. Specifically, by leveraging RIKEN's strength in research and SPI's connections with and experience in domestic and foreign pharmaceutical companies, they will strive to promote technology transfer and commercialization of findings and patents provided by RIKEN.

Japan Corporate News Network (http://www.japancorp.net/Article.Asp?Art_ID=9573)